Drugs / Germinal peptide
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03967548 | Apr → May 2021 | corneal disorder | Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT03662971 | Oct → Dec 2018 | corneal disorder | Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Germinal peptide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03967548 ↗ |
| Modality | Peptide | “Germinal peptide eye drops” NCT03662971 ↗ |
| Route | Topical | “Germinal peptide eye drops” NCT03662971 ↗ |